SPO11

gene
On this page

Also known as CT35SPATA43TOPVIATOPOVIA

Summary

SPO11 (SPO11 initiator of meiotic double strand breaks, HGNC:11250) is a protein-coding gene on chromosome 20q13.31, encoding Meiotic recombination protein SPO11 (Q9Y5K1). Component of a topoisomerase 6 complex specifically required for meiotic recombination.

Meiotic recombination and chromosome segregation require the formation of double-strand breaks (DSBs) in paired chromosome homologs. During meiosis in yeast, a meiotic recombination protein is covalently-linked to the 5’ end of DSBs and is essential for the formation of DSBs. The protein encoded by this gene is similar in sequence and conserved features to the yeast meiotic recombination protein. The encoded protein belongs to the TOP6A protein family. Several transcript variants encoding different isoforms have been found for this gene, but the full-length nature of only two of them have been described.

Source: NCBI Gene 23626 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 43 total — 1 likely-pathogenic
  • MANE Select transcript: NM_012444

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:11250
Approved symbolSPO11
NameSPO11 initiator of meiotic double strand breaks
Location20q13.31
Locus typegene with protein product
StatusApproved
AliasesCT35, SPATA43, TOPVIA, TOPOVIA
Ensembl geneENSG00000054796
Ensembl biotypeprotein_coding
OMIM605114
Entrez23626

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 4 protein_coding, 1 nonsense_mediated_decay

ENST00000345868, ENST00000371260, ENST00000371263, ENST00000418127, ENST00000494972

RefSeq mRNA: 2 — MANE Select: NM_012444 NM_012444, NM_198265

CCDS: CCDS13456, CCDS13457

Canonical transcript exons

ENST00000371263 — 13 exons

ExonStartEnd
ENSE000005110065733318857333276
ENSE000006629285733183357331946
ENSE000006629345733579857335907
ENSE000008457325733368757333753
ENSE000008457335733398757334095
ENSE000008457345733475057334836
ENSE000008457355733541957335455
ENSE000008457375733827657338375
ENSE000008457395734010257340178
ENSE000014316685732980357329998
ENSE000035031005734272957342840
ENSE000037845115733898957339026
ENSE000038890395734334157343993

Expression profiles

Bgee: expression breadth broad, 20 present calls, max score 92.48.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0075 / max 7.6684, expressed in 3 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1854650.00753

Top tissues by expression

272 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099192.48gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047387.99gold quality
right testisUBERON:000453474.54gold quality
left testisUBERON:000453372.93gold quality
testisUBERON:000047372.36gold quality
secondary oocyteCL:000065558.49silver quality
adult organismUBERON:000702353.00gold quality
lower lobe of lungUBERON:000894949.56silver quality
Brodmann (1909) area 46UBERON:000648349.30gold quality
blood vessel layerUBERON:000479749.29gold quality
cervix squamous epitheliumUBERON:000692249.20gold quality
hair follicleUBERON:000207349.18gold quality
olfactory bulbUBERON:000226448.92gold quality
quadriceps femorisUBERON:000137748.90gold quality
choroid plexus epitheliumUBERON:000391148.89gold quality
myocardiumUBERON:000234948.87gold quality
type B pancreatic cellCL:000016948.83gold quality
oviduct epitheliumUBERON:000480448.73gold quality
epithelial cell of pancreasCL:000008348.56gold quality
tibialis anteriorUBERON:000138548.55silver quality
cardiac muscle of right atriumUBERON:000337948.55gold quality
CA1 field of hippocampusUBERON:000388148.50gold quality
vastus lateralisUBERON:000137948.44gold quality
left ventricle myocardiumUBERON:000656648.24gold quality
orbitofrontal cortexUBERON:000416748.20gold quality
upper arm skinUBERON:000426348.06gold quality
cervix epitheliumUBERON:000480148.04gold quality
tongue squamous epitheliumUBERON:000691947.92gold quality
mucosa of urinary bladderUBERON:000125947.80gold quality
nasal cavity epitheliumUBERON:000538447.70gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.76

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

47 targeting SPO11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-5692B100.0071.322622
HSA-MIR-5692C100.0071.322622
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-5692A100.0074.406850
HSA-MIR-3692-3P99.9870.272139
HSA-MIR-56899.9869.862084
HSA-MIR-548AN99.9770.912817
HSA-MIR-365899.9673.874379
HSA-MIR-651-3P99.9473.485177
HSA-MIR-314399.9371.963104
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-374A-5P99.9071.342923
HSA-MIR-374B-5P99.9069.982734
HSA-MIR-579-3P99.8671.663628
HSA-MIR-664B-3P99.8471.653590
HSA-MIR-132399.8369.892471
HSA-MIR-205299.7969.372031
HSA-MIR-6885-3P99.7570.363187
HSA-MIR-548O-3P99.7469.302228
HSA-MIR-518A-5P99.7069.012209
HSA-MIR-52799.7069.012209
HSA-MIR-379-3P99.6969.601524
HSA-MIR-411-3P99.6969.631524
HSA-MIR-548BA99.6969.141514
HSA-MIR-1212399.5271.792990
HSA-MIR-312899.5067.851258
HSA-MIR-183-3P99.4169.411598

Literature-anchored findings (GeneRIF, showing 7)

  • Mutations in the human SPO11 gene are not common causes of infertility in man (PMID:16169419)
  • Data show that there is no association between SPO11 gene mutation and premature ovarian failure. (PMID:18166824)
  • SPO11 might has an effect on premorbid functioning, which increase susceptibility for idiopathic male reproduction (PMID:21556891)
  • Polymorphisms within the SPO11 gene are linked to the susceptibility of azoospermia and oligozoospermia male infertility. (PMID:25005169)
  • Data suggest that the combined genotypes of glutathionine S-transferase GSTM1 (-/-), GSTT1 (+/+), GSTP1 (AA) and meiotic recombination protein SPO11 (CT) may be associated with idiopathic male infertility in ethnic Han Chinese. (PMID:26663067)
  • SPO11 gene C631T polymorphism may contribute as a genetic factor susceptible to cause male infertility in Chinese. (PMID:28050928)
  • Centromeres are dismantled by foundational meiotic proteins Spo11 and Rec8. (PMID:33658710)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriospo11ENSDARG00000013837
mus_musculusSpo11ENSMUSG00000005883
rattus_norvegicusSpo11ENSRNOG00000006732
drosophila_melanogastermei-W68FBGN0002716
caenorhabditis_elegansWBGENE00004985

Protein

Protein identifiers

Meiotic recombination protein SPO11Q9Y5K1 (reviewed: Q9Y5K1)

Alternative names: Cancer/testis antigen 35

All UniProt accessions (4): Q9Y5K1, H0YCK9, Q5TCH6, Q5TCH7

UniProt curated annotations — full annotation on UniProt →

Function. Component of a topoisomerase 6 complex specifically required for meiotic recombination. Together with TOP6BL, mediates DNA cleavage that forms the double-strand breaks (DSB) that initiate meiotic recombination. The complex promotes relaxation of negative and positive supercoiled DNA and DNA decatenation through cleavage and ligation cycles. Essential for the phosphorylation of SMC3, HORMAD1 and HORMAD2.

Subunit / interactions. Heterotetramer of SPO11 and 2 TOP6BL chains. Interacts with TOP6BL.

Subcellular location. Nucleus.

Tissue specificity. Highly expressed in testis.

Similarity. Belongs to the TOP6A family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9Y5K1-11yes
Q9Y5K1-22

RefSeq proteins (2): NP_036576, NP_937998 (=MANE)

Domains & families (InterPro)

IDNameType
IPR002815Spo11/TopoVI_AFamily
IPR004084Meiosis_Spo11Domain
IPR013048Meiotic_Spo11Family
IPR013049Spo11/TopoVI_A_NDomain
IPR034136TOPRIM_Topo6A/Spo11Domain
IPR036078Spo11/TopoVI_A_sfHomologous_superfamily
IPR036388WH-like_DNA-bd_sfHomologous_superfamily

Pfam: PF03533, PF04406, PF21180

UniProt features (10 total): sequence variant 4, binding site 2, chain 1, domain 1, active site 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9Y5K1-F191.120.80

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 138 (o-(5’-phospho-dna)-tyrosine intermediate)

Ligand- & substrate-binding residues (2): 224; 277

Function

Pathways and Gene Ontology

Reactome pathways

4 pathways

IDPathway
R-HSA-912446Meiotic recombination
R-HSA-1474165Reproduction
R-HSA-1500620Meiosis
R-HSA-1640170Cell Cycle

MSigDB gene sets: 187 (showing top): GOBP_MEIOTIC_CHROMOSOME_SEGREGATION, REACTOME_MEIOTIC_RECOMBINATION, GOBP_CHROMOSOME_ORGANIZATION, GOBP_CHROMOSOME_LOCALIZATION, GOBP_OOGENESIS, GOBP_MALE_GAMETE_GENERATION, KAUFFMANN_DNA_REPAIR_GENES, GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION, TCF4_Q5, GOBP_OVARIAN_FOLLICLE_DEVELOPMENT, GOBP_ORGANELLE_FISSION, GOBP_REPRODUCTIVE_SYSTEM_DEVELOPMENT, GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME, GOBP_DNA_DAMAGE_RESPONSE, GOBP_MALE_MEIOSIS_I

GO Biological Process (16): meiotic DNA double-strand break processing (GO:0000706), ovarian follicle development (GO:0001541), synaptonemal complex assembly (GO:0007130), reciprocal meiotic recombination (GO:0007131), male meiosis I (GO:0007141), spermatogenesis (GO:0007283), spermatid development (GO:0007286), female gamete generation (GO:0007292), protein localization to chromosome (GO:0034502), meiotic DNA double-strand break formation (GO:0042138), meiotic telomere clustering (GO:0045141), oogenesis (GO:0048477), double-strand break repair involved in meiotic recombination (GO:1990918), DNA metabolic process (GO:0006259), homologous chromosome pairing at meiosis (GO:0007129), meiotic cell cycle (GO:0051321)

GO Molecular Function (8): DNA binding (GO:0003677), DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity (GO:0003918), ATP binding (GO:0005524), metal ion binding (GO:0046872), catalytic activity (GO:0003824), DNA topoisomerase activity (GO:0003916), protein binding (GO:0005515), isomerase activity (GO:0016853)

GO Cellular Component (4): nuclear chromosome (GO:0000228), chromosome, telomeric region (GO:0000781), nucleus (GO:0005634), chromosome (GO:0005694)

Reactome top-level categories

Rollup of top-3 pathways:

CategoryPathways
Meiosis1
Reproduction1
Cell Cycle1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
meiotic cell cycle process3
chromosome organization involved in meiotic cell cycle3
meiotic cell cycle2
meiosis I2
male gamete generation2
germ cell development2
DNA double-strand break processing1
female gonad development1
anatomical structure development1
homologous chromosome pairing at meiosis1
cellular component assembly1
synaptonemal complex organization1
reciprocal homologous recombination1
male meiotic nuclear division1
developmental process involved in reproduction1
spermatid differentiation1
gamete generation1
protein localization to organelle1
DNA metabolic process1
meiosis I cell cycle process1
telomere localization1
chromosome localization to nuclear envelope involved in homologous chromosome segregation1
female gamete generation1
double-strand break repair1
reciprocal meiotic recombination1
nucleic acid metabolic process1
homologous chromosome segregation1
cell cycle1
sexual reproduction1
reproductive process1
meiotic nuclear division1
nucleic acid binding1
DNA topoisomerase activity1
ATP-dependent activity, acting on DNA1
adenyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
cation binding1
molecular_function1
DNA binding1
nucleic acid conformation isomerase activity1

Protein interactions and networks

STRING

2118 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SPO11TOP6BLQ8N6T0986
SPO11REC8O95072907
SPO11HORMAD1Q86X24897
SPO11RAD51Q06609893
SPO11MEI1Q5TIA1881
SPO11MSH4O15457875
SPO11PRDM9Q9NQV7871
SPO11SKIC8Q9GZS3868
SPO11REC114Q7Z4M0866
SPO11MSH5O43196845
SPO11SYCP3Q8IZU3844
SPO11EXO1Q9UQ84843
SPO11SLC39A1Q9NY26838
SPO11HORMAD2Q8N7B1815
SPO11RNF212Q495C1813

IntAct

4 interactions, top by confidence:

ABTypeScore
SPO11TUBB8psi-mi:“MI:0915”(physical association)0.400
ATF1ESYT2psi-mi:“MI:0914”(association)0.350
CEBPASAP18psi-mi:“MI:0914”(association)0.350
STAT3NACApsi-mi:“MI:0914”(association)0.350

BioGRID (3): SPO11 (Affinity Capture-MS), TCF4 (Two-hybrid), TUBB8 (Affinity Capture-MS)

ESM2 similar proteins: A0A0U1RQE8, A3BLS0, B2RXZ1, B6DMK2, O22190, O24357, O81829, O82243, O82333, O82504, P0C0M2, P0C0M3, Q0D4Z6, Q16P87, Q28CZ9, Q3EBC8, Q43839, Q4V8A1, Q4V8Q1, Q502J0, Q5R6R6, Q654M1, Q655R6, Q6J756, Q6QR59, Q6ZLA3, Q6ZLA7, Q7L7V1, Q7TS68, Q8GZ29, Q8LGM7, Q8LQM5, Q8NA58, Q969I3, Q9C5X8, Q9D5U0, Q9FZ87, Q9LND7, Q9LQ68, Q9LSQ4

Diamond homologs: A2BLE8, A2XFC1, B0R4D2, O05208, O27089, O29322, O59209, P40384, Q0DSV9, Q2QM00, Q3IPW7, Q57815, Q5JH82, Q5V4R4, Q5ZPI9, Q5ZPV8, Q6ZD95, Q7KPA5, Q7Y021, Q8TQF8, Q8U0K9, Q971T1, Q9HR32, Q9LZ03, Q9M4A1, Q9M4A2, Q9WTK8, Q9Y5K1, Q9YE67, C4VB43, P23179, Q22236, Q468I6, Q8PUB7, Q9V134, Q8SVS9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

43 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic1
Uncertain significance39
Likely benign1
Benign1

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
1244233NM_012444.3(SPO11):c.744G>A (p.Thr248=)Likely pathogenic

SpliceAI

1935 predictions. Top by Δscore:

VariantEffectΔscore
20:57329927:G:GTdonor_gain1.0000
20:57331947:G:GGdonor_gain1.0000
20:57333168:T:TAacceptor_gain1.0000
20:57333174:A:AGacceptor_gain1.0000
20:57333175:A:Gacceptor_gain1.0000
20:57333178:A:AGacceptor_gain1.0000
20:57333178:AAAAT:Aacceptor_gain1.0000
20:57333179:A:Gacceptor_gain1.0000
20:57333180:A:AGacceptor_gain1.0000
20:57333272:ATTTT:Adonor_gain1.0000
20:57333273:TTTT:Tdonor_gain1.0000
20:57333274:TTT:Tdonor_gain1.0000
20:57333275:TT:Tdonor_gain1.0000
20:57333277:G:GGdonor_gain1.0000
20:57333983:ATAG:Aacceptor_gain1.0000
20:57333983:ATAGG:Aacceptor_gain1.0000
20:57334092:TATA:Tdonor_gain1.0000
20:57334093:ATA:Adonor_gain1.0000
20:57334094:TA:Tdonor_gain1.0000
20:57334095:AGTAA:Adonor_loss1.0000
20:57334096:G:GGdonor_gain1.0000
20:57334096:GT:Gdonor_loss1.0000
20:57334097:TAAGT:Tdonor_loss1.0000
20:57334098:AAGTA:Adonor_loss1.0000
20:57334747:CA:Cacceptor_loss1.0000
20:57334748:A:AGacceptor_gain1.0000
20:57334748:AGTT:Aacceptor_loss1.0000
20:57334749:G:GGacceptor_gain1.0000
20:57334749:GT:Gacceptor_gain1.0000
20:57334749:GTT:Gacceptor_gain1.0000

AlphaMissense

2613 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
20:57335837:A:TK225I0.999
20:57334765:G:CG176R0.997
20:57335834:A:TE224V0.997
20:57338277:G:AG249E0.996
20:57338305:A:CR258S0.996
20:57338305:A:TR258S0.996
20:57338362:T:AD277E0.996
20:57338362:T:GD277E0.996
20:57340147:T:AW310R0.996
20:57340147:T:CW310R0.996
20:57335858:T:CL232P0.995
20:57343452:T:AW395R0.995
20:57343452:T:CW395R0.995
20:57333987:G:CR134S0.994
20:57333987:G:TR134S0.994
20:57334766:G:AG176D0.994
20:57338276:G:AG249R0.994
20:57338276:G:CG249R0.994
20:57338289:C:AP253H0.994
20:57338361:A:TD277V0.994
20:57335842:G:CA227P0.993
20:57338277:G:TG249V0.993
20:57338360:G:CD277H0.993
20:57339019:G:AG292E0.993
20:57343371:G:CA368P0.993
20:57343436:A:CK389N0.993
20:57343436:A:TK389N0.993
20:57335835:A:CE224D0.992
20:57335835:A:TE224D0.992
20:57338304:G:CR258T0.992

dbSNP variants (sampled 300 via entrez): RS1000010226 (20:57337785 A>G), RS1000148419 (20:57343889 T>C), RS1000177783 (20:57331285 C>T), RS1000232361 (20:57330008 C>G), RS1000372374 (20:57336673 T>C), RS1000565163 (20:57328986 G>A,T), RS1000842706 (20:57331613 G>A,C), RS1000853131 (20:57342198 T>A), RS1001278523 (20:57331037 T>A), RS1001374166 (20:57337949 G>A), RS1001647840 (20:57331330 G>C), RS1001737200 (20:57339758 A>G), RS1001853579 (20:57343991 G>A), RS1002340704 (20:57328748 C>A,T), RS1002443418 (20:57334583 A>T)

Disease associations

OMIM: gene MIM:605114 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST90002383_303Hematocrit1.000000e-12
GCST90002384_475Hemoglobin3.000000e-10

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004348hematocrit
EFO:0004509hemoglobin measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneincreases expression, increases methylation2
bisphenol Aincreases expression1
Valproic Aciddecreases methylation1
Aflatoxin B1decreases methylation1
Sodium Selenitedecreases expression1
Copper Sulfatedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.